The fight against the liver disease hepatitis C has been at something of an impasse for years, with more than 150 million people currently infected, and traditional antiviral treatments causing nasty side effects and often falling short of a cure. Using a novel technique, medical and engineering researchers at Stanford have discovered a vulnerable step in the virus' reproduction process that in lab testing could be effectively targeted with an obsolete antihistamine.

Tagged: Bio-X, bioengineering, hepatitus, Human Health, Engineering, Medicine

Three young Americans and the Stanford Asian Liver Center seek to stop hepatitus B in China by immunizing 500,000 rural children and educating the community about the disease.

Tagged: alumni, China, hepatitus, immunization, Human Health, International Issues, Public Service, Humanities & Sciences, Medicine